The Medical Device Business Journal — Medical Device News & Articles | MassDevice
An international group of medical device regulators, the Global Harmonization Task Force, is giving the boot to industry representatives.
The founding regulatory bodies of the group, formed to hammer out global standards for medical devices, decided to terminate the organization and start over — without trade groups as members.
Advanced Medical Technology Assn. hired veteran policy analyst Tharini Sathiamoorthy for a top spot in its diagnostics division.
The Washington, D.C.-based medical device industry council tapped Sathiamoorthy to be associate vice president of AdvaMedDx, which focuses the "opportunities and challenges" that face diagnostic technology firms.
The Mass. Life Sciences Center doled out $24.5 million worth of tax incentives to 28 life science companies in the Bay State, aiming to foster the creation of 918 new jobs, but half of the firms failed to create the jobs they promised.
The Commonwealth created the MLSC as a quasi-government agency to administer the $1 billion allocated by Gov. Deval Patrick’s 2006 life sciences bill.
2009 was a tough year for U.S. technology transfer programs, which saw licensing income drop 32 percent, according to a survey published by trade group the Association of University Technology Managers.
The 181 tech transfer programs that responded to the survey reported a combined $2.3 billion in income.
The Advanced Medical Technology Assn. spent $358,264 lobbying legislators in Washington, D.C., during the third quarter of 2010, mainly trying to have a say in the healthcare reform push and its varied proposals to tax the medical device industry.
That’s down from AdvaMed’s $379,000 Q2 lobbying spend and even lower than the first quarter, when the trade group dropped a cool $385,000 on lobbying in D.C., all with an eye toward influencing the final shape of the Patient Protection and Affordable Care Act.
The Mass. Life Sciences Center, a quasi-public agency that oversees state dollars allocated toward increasing the life sciences industry’s footprint in the Bay State, announced the second year of its small business matching grants program.
The quasi-public agency plans to dole out up to $3 million in grants of up to $500,000 each that match Phase II or post-Phase II small business innovation research or small business technology transfer grants from federal agencies.
Stephen Ubl
CEO, AdvaMed
During the historic debate on healthcare reform that consumed much of the last two years, Advamed CEO Stephen Ubl was a constant, albeit quiet, presence at the negotiating table between President Barack Obama and the healthcare industry.
The Mass. Life Sciences Center doled out $24 million worth of tax incentives to 30 life science companies in the Bay State, aimed at fostering the creation of 1,000 new jobs here.
The center‘s Life Sciences Tax Incentive Program calls for it to dispense the $25 million in tax breaks each year, to boost the state’s “super cluster” of medical device, pharmaceutical and biotech firms.
Accountable care organizations, new payment programs for doctors established by the healthcare reform act, are intended to control the unchecked costs that the fee for service system encourages.
There is a risk, however, that ACOs could keep the best possible care from patients and stifle innovation, according to the Advanced Medical Technology Assn., or AdvaMed, which represents the medical device industry.
LifeImage Inc. won a two-year federally-funded medical image-sharing contract.
The Newton, Mass.-based healthcare IT firm was selected by the Radiological Society of North America to serve as a digital "clearinghouse" for an imaging project funded by the National Institute of Health.
More than three-quarters of the cost to bring a medical device from concept to the U.S. market is spent clearing regulatory hurdles, according to a Stanford University report.
